Making It Stick: Considerations and Case Studies for Optimizing Use and Implementation of Long-Acting Antiretroviral Therapy

Why Attend:

The advent of long-acting injectable (LAI) antiretroviral therapy (ART) is rapidly transforming the landscape of care and treatment for persons with HIV (PWH). LAI ART provides a long-awaited alternative to, and has several advantages over, daily oral pills, such as the potential to reduce pill fatigue, burden, or intolerance and help overcome HIV-related stigma and fear of disclosure. However, there are key clinical considerations required to use this novel therapy and implementation of LAI ART in the clinic has been challenging.

Join this engaging, case-based webinar designed to enhance your clinical and functional knowledge of using and implementing long-acting ART options for HIV treatment in your clinic. You’ll gain practical strategies to:

Select, initiate and monitor use of LAI ART agents based on key criteria for safety and efficacy
Incorporate frameworks for considering LAI ART use in PWH with adherence challenges and/or viremia
Guide strategies for coordinating LAI ART use and implementation in your clinic/ health system.

Stay up to date with evolving best practices and learn how to align your approach with current treatment guidelines and supportive real-world data on using LAI ART in PWH for improved individual and public health outcomes. This session also emphasizes team-based, interprofessional care, offering actionable insights to enhance collaboration, care coordination, and patient outcomes across the HIV care continuum.

What You Can Expect:

Practical Application of the Science: Our expert faculty educators will guide you through this engaging and informative program, and offer suggestions on how you can apply the latest science to patient care.
Patient-Centered Care: Learn from faculty who are directly involved in patient care about strategies for providing compassionate care that addresses individuals’ unique needs and challenges.
Team Focused: Explore how HIV clinicians from multiple professions are collaborating to optimize patient care.
Interactive: Engage in case studies and Q&A with faculty educators, enhancing your practical skills and knowledge.

By participating, you'll not only enhance your professional development but also be better prepared to contribute as an HIV team member toward better healthcare outcomes for your patients.

Activity Co-Faculty:

Lauren F. Collins, MD, MSc

Assistant Professor of Medicine Division of Infectious Diseases Emory University School of Medicine Grady Ponce de Leon Center Atlanta, GA

Eric Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist Indiana University Health LifeCare Clinic Methodist Hospital Indianapolis, Indiana

Lauren F. Collins, MD, MSc is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine. She attends inpatient ID/HIV services at Grady Memorial Hospital and is a primary care physician at the Grady Ponce de Leon Center in the women’s clinic. Since 2021, she has served as the Medical Director of the Grady Ponce Long-acting Antiretroviral Therapy Program. Dr. Collins’s clinical and research interests focus on improving the care and outcomes of persons with HIV across the lifespan, and in particular, women and those affected by the Southern HIV/AIDS epidemic. In her research, she studies the development and associated risk factors of aging-related multimorbidity with an emphasis on sex differences and overall goal of optimizing comorbidity screening and prevention strategies in this population. She is also interested in leveraging long-acting antiretroviral therapy as a tool to help end the HIV Epidemic through mixed methods and implementation science research. Dr. Collins is a co-investigator of multiple NIH-funded prospectively-enrolled longitudinal observational cohort studies centered on evaluating health priorities for women with and without HIV, including the MACS/WIHS Combined Cohort Study (MWCCS), the Study of Treatment And Reproductive Outcomes (STAR), and the Emory Specialized Center of Research Excellence (SCORE) on Sex Differences. Her comorbidity work is supported by a K23 Award from the National Institute on Aging and she also serves as the PI of a CDC U01 “A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Black Women across Six Ending the HIV Epidemic Jurisdictions in the South.”

Eric Farmer, PharmD, BCPS, AAHIVP graduated from Butler University with his Doctor of Pharmacy. He then completed an ASHP-accredited PGY1 pharmacy residency at Eskenazi Health (formerly Wishard Health Services) in Indianapolis, Indiana and subsequently an ASHP-accredited PGY2 HIV specialty pharmacy residency at the Center for HIV/AIDS Care and Research at Boston Medical Center in Boston, Massachusetts. Dr. Farmer is currently an HIV clinical pharmacist at the Indiana University Health LifeCare Clinic located at Methodist Hospital in Indianapolis, Indiana. At LifeCare, Dr. Farmer provides pharmacy services that include medication adherence counseling and patient education, drug information services, medication procurement, medication therapy management, and medical care coordination services. He currently serves as a clinical preceptor for APPE students, PGY1 residents, and PGY2 residents at IU Health as well as serves as clinical faculty for the Midwest AIDS Training and Education Center. Dr. Farmer is a member of the Board of Directors for the American Academy of HIV Medicine.

Physicians

American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:

American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours (pending pharmacotherapeutic contact hours).

California

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.

Physician Assistants:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacists:

This activity provides 1.0 ACPE contact hours (0.1 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-25-038-L02-P, Knowledge.

Instructions on How to Receive Credit

There are no fees to participate in the activity. Participants must register and participate in the live activity. To receive CME/CE credit for your participation, please follow the directions at the conclusion of the program and complete the program evaluation.

CE certificates will be distributed via email to non-pharmacists. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacy learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy/ACTHIV® Institute. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2025. This accredited continuing education activity is held as copyrighted © by American Academy of CME. Through this notice, permission is granted for its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).